Madrigal Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resme…
Biotechnology
US, West Conshohocken [HQ]
MDGL/Financial Reporting

Income Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
144.00 14.00 7.00 - - - - - - - - - - - - - - - - - - - - - - - -
EPS
81.55 -32.49 -35.14 -36.99 -44.48 -30.62 -401.56 -5.07 -2.54 -2.22 -4.73 -12.78 -14.58 -17.47 -19.99
Profit
144.00 14.00 7.00 - - - - - - - - - - - - - - - - - - - - - - - -
Pre Tax
79.00 -37.00 -47.00 -62.00 -90.00 -86.00 -68.00 -26.00 -31.00 -32.00 -83.00 -202.00 -241.00 -295.00 -373.00
ETR
1.84 - - - - - - - - - - - - - - 2.04 -23.99 13.27 2.37 0.32 -1.34 - -
Net
79.00 -37.00 -47.00 -62.00 -90.00 -86.00 -68.00 -26.00 -31.00 -32.00 -72.00 -197.00 -241.00 -299.00 -373.00
EBITDA
84.00 -34.00 -43.00 -60.00 -87.00 -83.00 -66.00 -25.00 -32.00 -40.00 -94.00 -206.00 -242.00 -291.00 -379.00
Operating Income
79.00 -36.00 -45.00 -60.00 -87.00 -83.00 -67.00 -25.00 -32.00 -40.00 -94.00 -206.00 -242.00 -293.00 -380.00
Interest Income
- - - - - - - - - - - - - - - - - - 7.00 11.00 4.00 - - 2.00 19.00
Loss
-63.00 -51.00 -53.00 -61.00 -87.00 -83.00 -67.00 -25.00 -32.00 -40.00 -94.00 -206.00 -242.00 -293.00 -380.00
Cost of Revenue
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Expenses
-63.00 -51.00 -53.00 -61.00 -87.00 -83.00 -67.00 -25.00 -32.00 -40.00 -94.00 -206.00 -242.00 -293.00 -379.00
Depreciation and Amortization
-2.00 -1.00 -1.00 - - - - - - - - - - - - - - - - - - - - - - - -
Interest Expenses
- - - - -1.00 -1.00 -2.00 -2.00 -1.00 -1.00 - - -7.00 -11.00 - - - - -3.00 -12.00
Other Expenses
-1.00 - - -1.00 -1.00 -2.00 -2.00 -1.00 -1.00 - - - - -11.00 -4.00 - - -1.00 -6.00
WA Shares Outstanding
- - 1.00 1.00 1.00 2.00 2.00 - - 5.00 12.00 14.00 15.00 15.00 16.00 17.00 18.00
End of MDGL's Analysis
CIK: 1157601 CUSIP: 558868105 ISIN: US5588681057 LEI: - UEI: -
Secondary Listings
MDGL has no secondary listings inside our databases.